David P. Horowitz

1.3k total citations · 1 hit paper
66 papers, 781 citations indexed

About

David P. Horowitz is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David P. Horowitz has authored 66 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 24 papers in Surgery and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David P. Horowitz's work include Advanced Radiotherapy Techniques (13 papers), Breast Cancer Treatment Studies (12 papers) and Pancreatic and Hepatic Oncology Research (11 papers). David P. Horowitz is often cited by papers focused on Advanced Radiotherapy Techniques (13 papers), Breast Cancer Treatment Studies (12 papers) and Pancreatic and Hepatic Oncology Research (11 papers). David P. Horowitz collaborates with scholars based in United States, Colombia and Canada. David P. Horowitz's co-authors include Eileen P. Connolly, Israel Deutsch, Subha Perni, Reshma Jagsi, Michael K. Rooney, Anne R. McCall, Daniel W. Golden, Andrew J. Einstein, Lisa A. Kachnic and Alfred I. Neugut and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

David P. Horowitz

60 papers receiving 770 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Readability of Patient Education Materials From High-Impact Medical Journals: A 20-Year Analysis

2021 165 citations David P. Horowitz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David P. Horowitz United States	14	262	175	139	135	130	66	781
Anne R. McCall United States	13	172 0.7×	251 1.4×	78 0.6×	90 0.7×	132 1.0×	37	844
Bethany Anderson United States	16	196 0.7×	174 1.0×	189 1.4×	242 1.8×	36 0.3×	48	738
Razvan Galalae Germany	11	136 0.5×	129 0.7×	162 1.2×	146 1.1×	48 0.4×	28	547
Agnès Tallet France	15	183 0.7×	293 1.7×	150 1.1×	332 2.5×	45 0.3×	53	764
Jennifer Croke Canada	14	148 0.6×	109 0.6×	153 1.1×	69 0.5×	55 0.4×	90	617
Maja Primic‐Žakelj Slovenia	17	642 2.5×	150 0.9×	243 1.7×	144 1.1×	43 0.3×	37	1.2k
Raphael Yechieli United States	17	208 0.8×	178 1.0×	294 2.1×	45 0.3×	42 0.3×	78	917
Nuran Beşe Türkiye	19	672 2.6×	196 1.1×	292 2.1×	228 1.7×	32 0.2×	44	1.3k
Divya Khosla India	14	168 0.6×	191 1.1×	257 1.8×	63 0.5×	32 0.2×	91	762
Liesbet Van Eycken Belgium	17	852 3.3×	165 0.9×	272 2.0×	198 1.5×	37 0.3×	59	1.2k

Countries citing papers authored by David P. Horowitz

Since Specialization

Citations

This map shows the geographic impact of David P. Horowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Horowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Horowitz more than expected).

Fields of papers citing papers by David P. Horowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David P. Horowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Horowitz. The network helps show where David P. Horowitz may publish in the future.

Co-authorship network of co-authors of David P. Horowitz

This figure shows the co-authorship network connecting the top 25 collaborators of David P. Horowitz. A scholar is included among the top collaborators of David P. Horowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David P. Horowitz. David P. Horowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Yi‐Rong, Jinzhong Yang, Percy Lee, David P. Horowitz, & Tarita O. Thomas. (2025). Adaptative Radiation Therapy. 5(1). 1–13. 1 indexed citations

Kachnic, Lisa A., et al.. (2024). Inappropriate Denials for Radiation Therapy in Medicare Advantage Plans. International Journal of Radiation Oncology*Biology*Physics. 121(4). 871–874. 1 indexed citations

Kennecke, Hagen F., Christopher J. O’Callaghan, Dongsheng Tu, et al.. (2024). The NEO-RT trial: A phase 3 randomized trial of neoadjuvant chemotherapy, excision and observation versus chemoradiotherapy for early rectal cancer, CCTG CO.32.. Journal of Clinical Oncology. 42(16_suppl). TPS3646–TPS3646. 1 indexed citations

Gallitto, Matthew, et al.. (2024). CT-guided online adaptive stereotactic body radiotherapy for pancreas ductal adenocarcinoma: Dosimetric and initial clinical experience. Clinical and Translational Radiation Oncology. 48. 100813–100813. 3 indexed citations

Horowitz, David P., et al.. (2024). CBCT-Guided Online Adaptive Radiotherapy for Rectal Cancer: Initial Dosimetric and Clinical Experience. International Journal of Radiation Oncology*Biology*Physics. 120(2). e459–e459.

Kinslow, Connor J., Soumyajit Roy, Fábio M. Iwamoto, et al.. (2024). The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas. Neuro-Oncology. 26(10). 1839–1849. 1 indexed citations

Kinslow, Connor J., Christine H. Rohde, James B. Yu, et al.. (2024). Systematic under-ascertainment of anaplastic large cell lymphoma cases in cancer registries: report from a comprehensive cancer center. Journal of Plastic Reconstructive & Aesthetic Surgery. 95. 49–51.

Morris, Van K., Erin B. Kennedy, Manik Amin, et al.. (2024). Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO Guideline. Journal of Clinical Oncology. 43(5). 605–615. 3 indexed citations

Rayn, Kareem, et al.. (2023). Scorecards: Quantifying Dosimetric Plan Quality in Pancreatic Ductal Adenocarcinoma Stereotactic Body Radiation Therapy. Advances in Radiation Oncology. 8(6). 101295–101295. 5 indexed citations

10.

Elliston, Carl D., et al.. (2023). Adaptive Radiation Therapy: A Review of CT-based Techniques. Radiology Imaging Cancer. 5(4). e230011–e230011. 30 indexed citations

11.

Kinslow, Connor J., Ali I. Rae, Kekoa Taparra, et al.. (2023). MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas. Clinical Cancer Research. 29(21). 4399–4407. 13 indexed citations

12.

Kinslow, Connor J., Mark Olfson, Melanie M. Wall, et al.. (2023). Prognosis and risk of suicide after cancer diagnosis. Cancer. 130(4). 588–596. 6 indexed citations

13.

Kinslow, Connor J., James B. Yu, Lisa A. Kachnic, et al.. (2023). Risk of Squamous Cell Carcinoma of the Breast Following Postmastectomy Implant Reconstruction in Women With Breast Cancer and Carcinoma in Situ. JAMA Surgery. 158(7). 769–769. 6 indexed citations

14.

Gallitto, Matthew, et al.. (2023). CT-Guided Online Adaptive Stereotactic Body Radiotherapy for Pancreas Ductal Adenocarcinoma: Dosimetric and Initial Clinical Experience. International Journal of Radiation Oncology*Biology*Physics. 117(2). e312–e312. 8 indexed citations

15.

Price, Michael, et al.. (2022). Impact of Adapted Radiotherapy Schedules on Bowel Sparing in Node-Positive Cervical Cancer. Practical Radiation Oncology. 13(2). e184–e191. 2 indexed citations

16.

Buss, Elizabeth, Lisa A. Kachnic, & David P. Horowitz. (2021). Radiotherapy for locally advanced pancreatic ductal adenocarcinoma. Seminars in Oncology. 48(1). 106–110. 10 indexed citations

17.

May, Michael, et al.. (2018). Comparing preoperative imaging modalities in patient selection for breast intraoperative radiotherapy. Journal of Surgical Oncology. 118(6). 959–965. 4 indexed citations

18.

Wu, Cheng–Chia, et al.. (2017). Koebner phenomenon: Consideration when choosing fractionation for breast irradiation. Advances in Radiation Oncology. 3(2). 108–110. 3 indexed citations

19.

Wu, Cheng–Chia, David P. Horowitz, Israel Deutsch, et al.. (2015). De-escalation of radiation dose for human papillomavirus-positive oropharyngeal head and neck squamous cell carcinoma: A case report and preclinical and clinical literature review. Oncology Letters. 11(1). 141–149. 4 indexed citations

20.

Horowitz, David P., Özlem Topaloglu, Yonggang Zhang, & Fred Bunz. (2008). Deficiency of Bloom syndrome helicase activity is radiomimetic. Cancer Biology & Therapy. 7(11). 1783–1786. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact